Kdfit Tablet is a pharmaceutical formulation containing Taurine 500 mg and Acetylcysteine 150 mg, designed to support cellular health and enhance antioxidant defenses. Taurine, a sulfur-containing amino acid, plays a critical role in cardiovascular function, osmoregulation, and modulation of calcium signaling, contributing to overall cellular stability and metabolic regulation. Acetylcysteine, a precursor to glutathione, acts as a potent antioxidant and mucolytic agent, facilitating the reduction of oxidative stress and promoting detoxification processes. The combination of Taurine and Acetylcysteine in Kdfit Tablet offers synergistic benefits, particularly in conditions characterized by oxidative damage, inflammation, and impaired cellular function. This formulation may be beneficial in supporting liver health, respiratory conditions with mucus hypersecretion, and metabolic disorders requiring enhanced antioxidant support. Kdfit Tablet is intended for use under medical supervision, with dosage and duration tailored to individual patient needs. It is contraindicated in individuals with known hypersensitivity to either component. Adverse effects are generally mild and infrequent but may include gastrointestinal discomfort or allergic reactions. Kdfit Tablet should be stored in a cool, dry place, away from direct sunlight, and kept out of reach of children. Consultation with a healthcare professional is recommended before initiating therapy to ensure safety and efficacy.